Create Post
4
STAT+: 5 lessons from Vinay Prasad’s turbulent tenure at the FDA

STAT+: 5 lessons from Vinay Prasad’s turbulent tenure at the FDA

(statnews.com)

Submitted 1 day ago by scrubbed_in

0 commentssharesavehidereport
0

0 comments

Sort:
Add a comment...

No comments yet

Health

A community for health content

0 subscribers

100% liked

Submitted by scrubbed_in to Health on 08 Mar 2026

Create post

Created by wellnoted, 1 week ago

Related posts
STAT+: A setback for Roche’s breast cancer drug
STAT+: A setback for Roche’s breast cancer drug
2 points · 0 comments · 4 hours ago
STAT+: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
STAT+: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
3 points · 0 comments · 5 hours ago
STAT+: Health tech company says it will dive into Medicare’s new chronic care experiment
STAT+: Health tech company says it will dive into Medicare’s new chronic care experiment
1 point · 0 comments · 10 hours ago
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
1 point · 0 comments · 1 day ago
Federal autism advisory board cancels first public meeting since overhaul
Federal autism advisory board cancels first public meeting since overhaul
1 point · 0 comments · 1 day ago